文献速递心境障碍

重性抑郁障碍治疗反应的领域衍生生物标志物:激活似然估计神经影像元分析

Domain-Derived Biomarkers of Treatment Response in Major Depressive Disorder: An Activation Likelihood Estimation Neuroimaging Meta-Analysis.
PubMed 文献 · Biol Psychiatry · 2026-09-09

该研究通过激活似然估计元分析,整合46项实验、996名重性抑郁障碍成人的预处理神经影像数据,发现右侧前脑岛在多个任务领域均与治疗反应差相关,而负性情绪加工任务中右侧前脑岛和膝下前扣带回的基线激活与治疗反应相关。静息态代谢研究和阳性治疗结局生物标志物研究未发现显著收敛。

要点

  • 右侧前脑岛预处理激活增高是重性抑郁障碍成人治疗反应差的跨领域生物标志物。
  • 负性情绪刺激诱发的右侧前脑岛和膝下前扣带回基线激活与后续治疗反应相关。
  • 静息态代谢研究及阳性治疗结局研究未发现显著收敛的生物标志物。

核心结论

  • 右侧前脑岛预处理激活增高是重性抑郁障碍成人治疗反应差的强生物标志物。
  • 负性情绪刺激诱发的边缘和旁边缘反应可能提供治疗反应信息。

研究设计与样本

  • 通过PubMed检索和综述参考文献筛选文献,纳入报告重性抑郁障碍成人预处理神经反应与抗抑郁药或认知行为治疗反应关系的研究。
  • 对峰值体素坐标进行激活似然估计元分析,识别领域通用和领域特异性生物标志物。
  • 元分析纳入46项实验,共996名独特参与者。

主要发现

  • 在显示预处理激活与治疗反应差相关的研究中,右侧前脑岛被识别为领域通用生物标志物。
  • 负性效价情绪加工领域的元分析显示,与治疗反应相关的基线激活在右侧前脑岛和膝下前扣带回显著收敛。
  • 静息态代谢研究或报告阳性治疗结局生物标志物的研究未发现显著收敛。

临床怎么用

  • 右侧前脑岛预处理激活增高可提示重性抑郁障碍成人治疗反应差的风险。
  • 负性情绪任务诱发的右侧前脑岛和膝下前扣带回激活可用于评估后续治疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuroimaging research in individuals with major depressive disorder (MDD) has identified varying deficits across affective, cognitive, and resting-state paradigms and distinct patterns of activation associated with these domains. Because this heterogeneity may be related to variation in clinical prognosis, we examined convergence across neuroimaging studies of MDD treatment biomarkers within and across domains. METHODS: Using a PubMed search and reference lists from topical reviews, we identified research in which adults with MDD exhibited pretreatment neural responses associated with clinical response to antidepressant medication or cognitive behavioral therapy. We performed activation likelihood estimation meta-analyses of peak voxel coordinates to identify domain-general (i.e., elicited across all tasks) and domain-specific (i.e., affective, cognitive, or resting-state) biomarkers associated with treatment response. RESULTS: The meta-analyses included 46 experiments with 996 unique participants. Across studies showing pretreatment activation associated with poor treatment outcome, a cluster in the right anterior insula (rAI) was identified as a domain-general biomarker. For the domain-specific meta-analysis of neuroimaging studies of negatively valenced emotion processing, significant convergence of baseline activation associated with treatment response emerged in the rAI and in the subgenual anterior cingulate cortex. No significant convergence of biomarkers emerged across resting-state metabolic studies or among studies reporting biomarkers of positive treatment outcomes. CONCLUSIONS: Across domains, heightened pretreatment activation in the rAI, which is a key node in the salience network, emerged as a strong biomarker of poor prognosis in adults with MDD. Moreover, pretreatment limbic and paralimbic responses elicited by negative emotional stimuli may provide valuable information about subsequent response to treatment.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. McCurry KL, Brown VM, Bansal V, et al. Domain-Derived Biomarkers of Treatment Response in Major Depressive Disorder: An Activation Likelihood Estimation Neuroimaging Meta-Analysis. Biol Psychiatry. 2026. PMID: 42413809. doi:10.1016/j.biopsych.2026.06.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。